Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands

British Journal of Pharmacology

Volumn 165, Issue 3, 2012, Pages 716-728

  Bardelli, C ^a   Amoruso, A ^a   Federici Canova, D ^a   Fresu, L G ^a   Balbo, P ^b   Neri, T ^c   Celi, A ^c   Brunelleschi, S ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

human monocytes; inflammatory cytokines; monocyte derived macrophages; Monocyte derived microparticles; NF KB; oxy radical production; PPAR ; rosiglitazone

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; CALCIMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; OXYGEN RADICAL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PHORBOL 13 ACETATE 12 MYRISTATE; ROSIGLITAZONE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOCRINE EFFECT; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE ACTIVATION; MEMBRANE MICROPARTICLE; MONOCYTE; MONOCYTE MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; SUPERNATANT;

CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; HUMANS; INTERLEUKIN-6; LIGANDS; MACROPHAGES; MONOCYTES; NF-KAPPA B; PPAR GAMMA; PROSTAGLANDIN D2; SUPEROXIDES; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855683135     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01593.x     Document Type: Article

References (45)

1. Aharon A, Tamari T, Brenner B, (2008). Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells. Thromb Haemost 100: 878-885.
2. Amoruso A, Bardelli C, Gunella G, Fresu LG, Ferrero V, Brunelleschi S, (2007). Quantification of PPAR-γ protein in monocyte/macrophages from healthy smokers and non-smokers: a possible direct effect of nicotine. Life Sci 81: 906-915. (Pubitemid 47374210)
3. Amoruso A, Bardelli C, Gunella G, Ribichini F, Brunelleschi S, (2008). A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-γ protein expression in human monocytes and macrophages. Br J Pharmacol 54: 144-152. (Pubitemid 351620392)
4. Amoruso A, Bardelli C, Fresu LG, Palma A, Vidali M, Ferrero V, et al,. (2009a). Enhanced Peroxisome Proliferator-Activated Receptor-γ expression in monocyte/macrophages from coronary artery disease patients and possible gender differences. J Pharmacol Exp Ther 331: 531-539.
5. Amoruso A, Gunella G, Rondano E, Bardelli C, Fresu LG, Ferrero V, et al,. (2009b). Tobacco smoke affects expression of peroxisome proliferator-activated receptor-gamma in monocyte/ macrophages of patients with coronary heart disease. Br J Pharmacol 58: 1272-1284.
6. Amoruso A, Bardelli C, Fresu LG, Poletti E, Palma A, Federici Canova D, et al,. (2010). The nitric oxide donating pravastatin, NCX 6550, inhibits cytokine release and NF-KB activation while enhancing PPARγ expression in human monocyte/macrophages. Pharmacol Res 62: 391-399.
7. Anderson HC, Mulhall D, Garimella R, (2010). Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Lab Invest 90: 1549-1557.
8. Asada K, Sasaki S, Suda T, Chida K, Nakamura H, (2004). Antiinflammatory roles of Peroxisome Proliferator-activated Receptor γ in human alveolar macrophages. Am J Respir Crit Care Med 169: 195-200. (Pubitemid 38114534)
9. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Zmbala M, (2007). Tumour-derived microvesicles modulate activity of human monocytes. Immun Lett 113: 76-82. (Pubitemid 47562121)
10. 1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-KB pathway. Br J Pharmacol 145: 385-396. (Pubitemid 40896083)
11. Barry OP, Pratico D, Savani RC, FitzGerald GA, (1998). Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 99: 2118-2127.
12. Berckmans RJ, Nieuwland R, Kraan MC, Schaap MCL, Pots D, Smeets TJM, et al,. (2005). Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res Ther 7: R536-R544.
13. Beyer C, Pisetsky DS, (2010). The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol 6: 21-29.
14. Carpintero R, Gruaz L, Brandt KJ, Scanu A, Faille D, Combes V, et al,. (2010). HDL interfere with the binding of T cell microparticles to human monocytes to inhibit pro-inflammatory cytokine production. PLoS ONE 5: e11869.
15. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, et al,. (1994). P-selectin induces the expression of tissue factor in monocytes. Proc Natl Acad Sci USA 91: 8767-8771.
16. Cerri C, Chimenti D, Conti I, Neri T, Paggiaro P, Celi A, (2006). Monocyte/macrophage-derived microparticles up-regulate inflammatory mediator synthesis by human airway epithelial cells. J Immun 177: 1975-1980. (Pubitemid 44092538)
17. Chen F, Wang M, O'Connor JP, He M, Tripathi T, Harrison LE, (2003). Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF-KB. J Cell Biochem 90: 732-744. (Pubitemid 37392464)
18. Dalli J, Norling LV, Renshaw D, Cooper D, Leung KY, Perretti M, (2008). Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. Blood 112: 2512-2519.
19. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA, (2005). Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106: 1604-1611. (Pubitemid 41208572)
20. Distler JHW, Huber LC, Huber AJ, Reich III CF, Gay S, Distler O, et al,. (2005a). The release of microparticles by apoptotic cells and their effects on macrophages. Apoptosis 10: 731-741. (Pubitemid 41187073)
21. Distler JHW, Pisetsky DS, Huber LC, Kalden JR, Gay S, Distler O, (2005b). Microparticles as regulators of inflammation. Novel players in cellular crosstalk in the rheumatic diseases. Arthritis Rheum 11: 3337-3348. (Pubitemid 41612200)
22. Esposito K, Ciotola M, Giugliano D, (2006). Pioglitazone reduces endothelial microparticles in the metabolic syndrome. Arterioscler Thromb Vasc Biol 26: 1926-1927. (Pubitemid 44305352)
23. Essayagh S, Xuereb JM, Terrisse AD, Tellier-Cirioni L, Pipy B, Sié P, (2007). Microparticles from apoptotic monocytes induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism. Thromb Haemost 98: 831-837. (Pubitemid 47555076)
24. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM, (2000). A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405: 85-90. (Pubitemid 30321820)
25. Gasser O, Schifferli JA, (2004). Activated polimorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 104: 2543-2548. (Pubitemid 39331859)
26. Gauley J, Pisetsky DS, (2010). The release of microparticles by RAW 264.7 macrophage cells stimulated with TLR ligands. J Leukoc Biol 87: 1115-1123.
27. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM, (2004). Membrane microparticles: two sides of the coin. Physiology 20: 22-27.
28. Jiang C, Ting AT, Seed B, (1998). PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86. (Pubitemid 28079219)
29. Koeppler B, Cohen C, Scloendorff D, Mack M, (2006). Differential mechanisms of microparticle transfer to B cells and monocytes: anti-inflammatory properties of microparticles. Eur J Immunol 36: 648-660.
30. Li M, Yu D, Williams KJ, Liu ML, (2010). Tobacco smoke induces the generation of procoagulant microvesicles from human monocyte/macrophages. Arterioscler Thromb Vasc Biol 30: 1818-1824.
31. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A, (1999). Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99: 348-353. (Pubitemid 29051259)
32. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, et al,. (2000). Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101: 841-843. (Pubitemid 30117876)
33. Mayr M, Grainger D, Mayr U, Leroyer AS, Leseche G, Sidibe A, et al,. (2009). Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques. Circ Cardiovasc Genet 2: 379-388.
34. Mesri M, Altieri DC, (1999). Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signalling pathway. J Biol Chem 274: 23111-23118.
35. Neri T, Armani C, Pegoli A, Cordazzo C, Camazzi Y, Brunelleschi S, et al,. (2011). Role of NF-KB and PPAR-γ in lung inflammation induced by monocyte-derived microparticles. Eur Respir J 37: 1494-1502.
36. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, Westendorp RG, et al,. (2000). Cellular origin of procoagulant properties of microparticles in meningococcal sepsis. Blood 95: 930-935. (Pubitemid 30063043)
37. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, et al,. (2005). A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 437: 759-763. (Pubitemid 41486547)
38. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ, (2006). Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20: 1487-1495. (Pubitemid 44264090)
39. Rautou PE, Leroyer AS, Ramkhelawon B, Devue C, Duflaut D, Vion AE, et al,. (2011). Microparticles from human atherosclerotic plaques promote endothelial ICAM-1 dependent monocyte adhesion and transendothelial migration. Circ Res 108: 335-343.
40. Ray DM, Spinelli SL, Pollock SJ, Murant TI, O'Brien JJ, Blumberg N, et al,. (2008). Peroxisome proliferator-activated receptor γ and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost 99: 86-95.
41. Reddy RC, Keshamouni VG, Jaigirdar SH, Zeng X, Leff T, Thannickal VJ, et al,. (2004). Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-γ ligands. Am J Physiol Lung Cell Mol Physiol 286: L613-L619. (Pubitemid 38233634)
42. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK, (1998). The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391: 79-82. (Pubitemid 28079218)
43. Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwege V, et al,. (1994). Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 153: 3245-3255. (Pubitemid 24292551)
44. Scanu A, Molnarfi N, Brandt KJ, Gruaz L, Dayer JM, Burger D, (2008). Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins. J Leukoc Biol 83: 921-927. (Pubitemid 351959872)
45. Tesse A, Al-Massarani G, Wangensteen R, Reitenbach S, Martinez MC, Andriantsitohaina R, (2008). Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, prevents microparticle-induced vascular hyporeactivity through the regulation of proinflammatory proteins. J Pharmacol Exp Ther 324: 539-547. (Pubitemid 351185832)